Is Methylene Blue Safe?

Methylene blue (MB) has exploded in popularity for its mitochondrial, cognitive, and antimicrobial benefits — but before anyone adds it to their wellness regimen, it's essential to understand how to use it safely and responsibly. While MB has a long history of medical use and is considered safe at appropriate doses, it’s not without risks. As with any compound that affects cellular metabolism and neurotransmitters, dose, drug interactions, and personal health history matter. So...is Methylene Blue safe? What are the Side Effects, Dosages, and Drug Interactions?

The Most Important Safety Concerns

1. Serotonin Syndrome - the most critical & potentially dangerous interaction 

Methylene blue is a reversible MAO-A inhibitor, meaning it can raise levels of serotonin, dopamine, and norepinephrine in the brain. This becomes problematic if MB is combined with SSRIs, SNRIs, TCAs, MAOIs, or even certain supplements like St. John’s Wort. It is an absolute contraindication if someone is currently taking:

• SSRIs (e.g. Zoloft, Prozac, Lexapro)

• SNRIs (e.g. Cymbalta, Effexor)

• Tricyclic antidepressants

• MAO inhibitors

• Certain opioids (like Demerol or tramadol)

They should not take methylene blue without full discontinuation and supervision from a qualified provider. Washout periods (usually 2–4 weeks) may be needed before it is safe to use MB.

Bottom line: If a patient is taking an antidepressant or serotonergic medication, MB can cause a potentially life-threatening condition known as serotonin syndrome — which includes symptoms like confusion, agitation, muscle rigidity, and dangerously high fevers.

2. G6PD Deficiency

Methylene blue is contraindicated in patients with G6PD deficiency, a common genetic enzyme disorder that affects the red blood cells’ ability to handle oxidative stress. Because MB has mild pro-oxidant effects in red blood cells, it can trigger hemolytic anemia (a dangerous breakdown of red blood cells) in those with G6PD deficiency. This condition is more common in people of African, Mediterranean, or Southeast Asian descent.

Bottom line: Anyone considering MB should screen for G6PD deficiency beforehand, especially if there is any family history or ethnic background suggesting increased risk.

3. Pregnancy and Breastfeeding

Methylene blue is not recommended during pregnancy — especially in the second and third trimesters. It’s been linked to fetal abnormalities like intestinal atresia when used in diagnostic procedures during pregnancy.

There is limited data on MB in breastfeeding, so it's generally advised to avoid during lactation unless absolutely necessary.

4. Overdose Risks

More is not better when it comes to MB. At therapeutic doses, MB acts as an antioxidant and mitochondrial enhancer. At very high doses, however, it becomes a pro-oxidant, potentially causing:

• Nausea, vomiting

• Dizziness or confusion

• Elevated blood pressure

• Paradoxical methemoglobinemia (the very condition it’s used to treat)

Safe dose ranges for functional medicine uses typically fall between 0.5 to 4 mg/kg/day, depending on the purpose and form used.

Common and Harmless Side Effects

These effects are usually not a cause for concern, though patients should be prepared for them:

Symptom	Cause	Notes
Blue or green urine	Renal excretion of MB	Completely benign; resolves after discontinuation
Green-tinged stool	GI elimination	Harmless but can stain toilet bowls
Taste disturbances	Oral MB	Some find it metallic or bitter
Mild nausea or GI upset	Especially with oral forms	Take with food to reduce symptoms
Headache or dizziness	Transient vasoconstriction or dose sensitivity	Usually resolves quickly

Routes of Administration and Dosing

Most patients do well starting at low doses (1–10 mg/day) for cognitive support or chronic illness support, then titrating slowly if needed.

Route	Use Case	Notes
IV	Emergency use (e.g. methemoglobinemia, septic shock)	Must be medical-grade; only in clinical settings
Oral (capsule/tablet)	Cognitive, fatigue, chronic infection support	Moderate bioavailability; common in functional medicine
Sublingual or buccal	Nootropic uses; improved absorption	Faster onset; may stain mouth temporarily
Topical	Photodynamic therapy (skin/mucosal infections)	Stains skin; not systemically absorbed in meaningful amounts
Inhalation or intrathecal	Highly experimental	Not advised without research protocol

Pharmaceutical vs. Aquarium Grade

NEVER use aquarium or textile-grade methylene blue for human consumption. These are not tested for:

• Heavy metals (e.g. lead, mercury)

• Sterility

• Dosage accuracy

Always source USP pharmaceutical-grade MB from a reputable compounding pharmacy or supplier.

Summary Safety Checklist

• G6PD screening completed

• No serotonergic medications or recent discontinuation

• Not pregnant or breastfeeding

• Using pharmaceutical-grade MB

• Starting at low dose (with food or sublingual form)

• Urine discoloration explained to patient

Final Thoughts

Methylene blue is powerful — and like any powerful tool, it must be used wisely. In the right hands, and with the right precautions, MB can be a safe, affordable, and versatile therapy for brain health, mitochondrial support, and chronic infections. But it’s not a DIY supplement — functional medicine providers should supervise use, especially when multiple conditions or medications are involved.

Want to Know if Methylene Blue is Safe For You?

Harmony Health Clinic offers guided methylene blue protocols for fatigue, brain fog, mold illness, and more — using only pharmaceutical-grade formulations.

Book a Consult

References

1. Clifton J 2nd, Leikin JB. Methylene blue. Am J Ther. 2003;10(4):289-291. doi:10.1097/01.mjt.0000031415.23512.46

2. Ng B, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics.2010;51(3):194-200. doi:10.1016/S0033-3182(10)70682-6

3. Schirmer RH, et al. Rejuvenation of methylene blue. Antioxid Redox Signal. 2011;14(2):1957–1967. doi:10.1089/ars.2010.3628

4. FDA Drug Safety Communication. Methylene blue may cause serious CNS reactions when given to patients taking certain psychiatric medications. U.S. Food and Drug Administration. https://www.fda.gov

5. ProvayBlue (methylene blue injection) Prescribing Information. American Regent, Inc. Revised 2016.

6. Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol. 2013;9(3):242-249. doi:10.1007/s13181-013-0311-1

7. Mayo Clinic. Methylene blue (oral route, injection route) – description and side effects. https://www.mayoclinic.org

8. Zhu H, et al. Methylene blue improves cognitive performance and mitochondrial function in aged mice. Brain Res.2012;1450:124–130. doi:10.1016/j.brainres.2012.02.054

9. Alam M, et al. A randomized split-face clinical trial of methylene blue 0.5% cream in skin aging. J Invest Dermatol. 2017;137(1):207–210. doi:10.1016/j.jid.2016.07.036

10. Yasuda H, et al. Methylene blue induces hemolysis in patients with G6PD deficiency. Blood. 2003;101(5):1971–1972. doi:10.1182/blood-2002-05-1443

11. Jansen EC, et al. Risk of birth defects from methylene blue use during pregnancy. Obstet Gynecol. 2003;101(5 Pt 2):1125–1129. doi:10.1016/S0029-7844(02)02699-6

12. International Programme on Chemical Safety. Methylene blue – Environmental Health Criteria. World Health Organization.